Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024

SELL
$1.3 - $2.15 $3,900 - $6,450
-3,000 Reduced 16.85%
14,800 $25,000
Q4 2023

Feb 14, 2024

SELL
$1.4 - $2.46 $15,119 - $26,568
-10,800 Reduced 37.76%
17,800 $34,000
Q3 2023

Nov 14, 2023

SELL
$2.31 - $4.18 $56,133 - $101,574
-24,300 Reduced 45.94%
28,600 $66,000
Q2 2023

Aug 11, 2023

BUY
$4.26 - $6.92 $135,042 - $219,364
31,700 Added 149.53%
52,900 $225,000
Q1 2023

May 16, 2023

SELL
$5.65 - $7.56 $7,345 - $9,828
-1,300 Reduced 5.78%
21,200 $143,000
Q4 2022

Feb 14, 2023

SELL
$5.47 - $7.9 $583,102 - $842,140
-106,600 Reduced 82.57%
22,500 $146,000
Q3 2022

Nov 14, 2022

BUY
$7.42 - $11.39 $152,110 - $233,495
20,500 Added 18.88%
129,100 $961,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $13.2M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.